oseltamivir has been researched along with Infections, Coronavirus in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (15.00) | 24.3611 |
2020's | 34 (85.00) | 2.80 |
Authors | Studies |
---|---|
Cao, R; Jiang, S; Li, Y; Liang, G; Liu, K; Meng, G; Shi, W; Wang, C; Wang, W; Xia, S; Zhang, T; Zhao, L; Zhong, W | 1 |
Ahmad, S; Davies, E; Farooq, HZ; Guiver, M; Hesketh, L; Machin, N; Turner, AJ | 1 |
Arabi, YM; Fowler, R; Hayden, FG | 1 |
Lu, X; Pan, B; Sun, P; Sun, W; Xu, C | 1 |
Duan, Y; Zhou, C; Zhu, HL | 1 |
Ding, D; Yao, W; Zhu, C | 1 |
Dai, J; Duan, J; Fu, Z; Lin, J; Tan, T | 1 |
Kutlu, Ö; Metin, A | 1 |
Rezaei, N; Yousefzadegan, S | 1 |
Cutrell, JB; Jodlowski, TZ; Monogue, ML; Sanders, JM | 1 |
Akyollu, B; Arpali, E; Kocak, B; Tekin, S; Turkmen, A; Yelken, B | 1 |
Albuquerque, BC; Alexandre, MAA; Baía-da-Silva, D; Balieiro, AAS; Bassat, Q; Borba, MGS; Brito, M; Brito-Sousa, JD; Croda, J; Daniel-Ribeiro, CT; Fontes, CJ; Guerra, MVF; Hajjar, LA; Lacerda, MVG; Melo, GC; Monteiro, WM; Mourão, MPG; Naveca, FG; Nogueira, ML; Pacheco, AGF; Pinto, RC; Romero, GAS; Sampaio, VS; Santos, JDO; Schwarzbold, A; Siqueira, AM; Val, FFA; Xavier, MS | 1 |
Bekci, T | 1 |
Daneshpazhooh, M; Isazade, A; Noormohammadpour, P; Soori, T | 1 |
Song, S; Wang, X; Xiong, Y; Ye, G | 1 |
Lu, G; Wang, J | 1 |
Ledford, H | 1 |
Aydın, GÇ; Azap, A; Dursun, B; Öztürk, HH; Ürün, Y; Utkan, G; Yazgan, SC; Yekedüz, E | 1 |
Berk, A; Duman, H; Kaya, F; Mutlu, H; Ozaras, R; Ucar, DH | 1 |
He, J; Huang, D; Li, J; Liang, W; Liu, L; Xia, Z; Xu, X; Zhao, Y | 1 |
Fujishima, S | 1 |
Du, Z; Galvani, AP; Krug, RM; Meyers, LA; Nugent, C | 1 |
Çapar, G; Köse, M; Medetalibeyoğlu, A; Şenkal, N; Tükek, T | 1 |
Bongard, E; Butler, CC; Cianci, D; Coenen, S; de Paor, M; Gobat, N; Goossens, H; Ieven, M; Saville, BR; van der Velden, AW; Verheij, TJ | 1 |
Amenta, F; Nittari, G; Pallotta, G; Tayebati, SK | 1 |
Firouzabadi, FD; Firouzabadi, MD; Ghalehbaghi, B; Goudarzi, S; Jahandideh, H; Roomiani, M | 1 |
Arish, M; Naz, F | 1 |
Altunok, ES; Cengel, F; Ekin, EE; Gurkan, O; Yilmaz, A | 1 |
Chen, C; Chen, Y; Hu, F; Liu, J; Song, J; Song, Y; Tang, X; Ye, M; Yin, G; Zhang, Y | 1 |
Chen, Y; Ding, M; Jiang, X; Lan, K; Lavillete, D; Li, H; Li, S; Liu, Y; Shan, J; Shang, W; Shen, Z; Sun, Y; Tong, Y; Wang, R; Wang, Y; Wu, Y; Xiao, G; Xiong, R; Xu, K; Xu, L; Zhang, L; Zhao, Y; Zhao, Z; Zhu, L; Zou, G | 1 |
Jiang, H; Xu, Y | 1 |
Akram, J; Azhar, S; Khan, KS; Latif, W; Shahzad, M | 1 |
Abd El Ghafar, MS; Abd-Elsalam, S; Abdo, EF; Ahmed, OA; Alboraie, M; Esmail, ES; Khalaf, M; Medhat, MA; Serangawy, GN; Soliman, S | 1 |
Esam, Z | 1 |
Ahmadinejad, Z; Assari, R; Ayoobi Yazdi, N; Javanshayani, P; Khalili Afousi, H; Mazloomi, SH; Ziaee, V | 1 |
Bleibtreu, A; Boutolleau, D; Caumes, E; Delemazure, J; Guillot, H; Houhou, N; Jaspard, M; Jaureguiberry, S; Lescure, FX; Lucet, JC; Mourvillier, B; Rioux, C; Robert, J; Vallois, D; Yazdanapanah, Y | 1 |
Badrul, AS; Chee Kheong, C; Fadzilah, K; Hirman, I; Lokman Hakim, S; Noor Hisham, A; Noraini, W; Norhayati, R; Premila Devi, J; Zainah, S | 1 |
Fry, AM; McKimm-Breschkin, JL | 1 |
Ariza-Heredia, EJ; Chemaly, RF; Shahani, L | 1 |
Brydak, LB; Donevski, S; Gawryluk, D; Romanowska, M; Stefanska, I | 1 |
5 review(s) available for oseltamivir and Infections, Coronavirus
Article | Year |
---|---|
Critical care management of adults with community-acquired severe respiratory viral infection.
Topics: Adult; Antiviral Agents; Community-Acquired Infections; Coronavirus Infections; COVID-19; Critical Care; Critical Illness; Evidence-Based Medicine; Humans; Influenza, Human; Intensive Care Units; Macrolides; Noninvasive Ventilation; Oseltamivir; Pneumonia; Pneumonia, Viral; Respiration, Artificial; Severe Acute Respiratory Syndrome; Severity of Illness Index | 2020 |
Understanding of COVID-19 based on current evidence.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Animals; Antiviral Agents; Betacoronavirus; China; Chiroptera; Communicable Disease Control; Coronavirus Infections; COVID-19; Disease Management; Humans; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Survival Analysis | 2020 |
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunoglobulins; Immunologic Factors; Indoles; Lopinavir; Oseltamivir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Withholding Treatment | 2020 |
Current pharmacological treatments for SARS-COV-2: A narrative review.
Topics: Adenosine Monophosphate; Adjuvants, Immunologic; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Immunity, Innate; Inflammation Mediators; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
Antiviral therapy for respiratory viral infections in immunocompromised patients.
Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Coronavirus Infections; Cyclopentanes; Guanidines; Humans; Immunocompromised Host; Influenza, Human; Oseltamivir; Palivizumab; Paramyxoviridae Infections; Picornaviridae Infections; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Zanamivir | 2017 |
4 trial(s) available for oseltamivir and Infections, Coronavirus
Article | Year |
---|---|
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Brazil; Chloroquine; Coronavirus Infections; COVID-19; Disease Outbreaks; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tertiary Care Centers | 2020 |
Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Europe; Female; Fever; Headache; Humans; Influenza, Human; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Time Factors; Treatment Outcome; Young Adult | 2020 |
Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A struc
Topics: Azithromycin; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Research Design; SARS-CoV-2 | 2020 |
RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.
Topics: Acetaminophen; Adult; Antiviral Agents; Betacoronavirus; Cephalosporins; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Repositioning; Egypt; Female; Humans; Hydrocortisone; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome | 2020 |
31 other study(ies) available for oseltamivir and Infections, Coronavirus
Article | Year |
---|---|
De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.
Topics: Alphainfluenzavirus; Amino Acid Sequence; Antiviral Agents; Coronavirus Infections; Drug Discovery; HEK293 Cells; Humans; Influenza, Human; Lipopeptides; Middle East Respiratory Syndrome Coronavirus; Protein Conformation, alpha-Helical; Viral Fusion Proteins; Virus Internalization | 2018 |
Middle East respiratory syndrome coronavirus (MERS-CoV) - Surveillance and testing in North England from 2012 to 2019.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Coronavirus Infections; England; Epidemiological Monitoring; Female; Humans; Infant; Influenza, Human; Male; Middle Aged; Middle East; Middle East Respiratory Syndrome Coronavirus; Oseltamivir; Polymerase Chain Reaction; Retrospective Studies; Travel-Related Illness; Young Adult | 2020 |
Advance of promising targets and agents against COVID-19 in China.
Topics: Adenine; Adenosine Monophosphate; Alanine; Amides; Antimalarials; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Cobicistat; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Dibenzothiepins; Drug Combinations; Drug Discovery; Drug Therapy, Combination; Emtricitabine; Humans; Hydroxychloroquine; Indoles; Lopinavir; Medicine, Chinese Traditional; Morpholines; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Pyrazines; Pyridines; Pyridones; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tenofovir; Thiepins; Triazines; Viral Nonstructural Proteins | 2020 |
A Cured Patient With 2019-nCoV Pneumonia.
Topics: Aged; Anti-Bacterial Agents; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Female; Humans; Moxifloxacin; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
The isolation period should be longer: Lesson from a child infected with SARS-CoV-2 in Chongqing, China.
Topics: Adult; Betacoronavirus; Child; China; Coronavirus Infections; COVID-19; Disease Transmission, Infectious; Family Health; Humans; Infection Control; Interferon-alpha; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |
A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?
Topics: Aged; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral; Psoriasis | 2020 |
Case Report: Death due to COVID-19 in Three Brothers.
Topics: Aged; Betacoronavirus; Coronavirus Infections; COVID-19; Fatal Outcome; Genetic Predisposition to Disease; Humans; Hydroxychloroquine; Iran; Lung; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Siblings; Tomography, X-Ray Computed | 2020 |
Case report: A kidney transplant patient with mild COVID-19.
Topics: Adult; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Treatment; Disease Management; Female; Fever; Glucocorticoids; Graft Rejection; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lupus Nephritis; Oseltamivir; Pandemics; Pneumonia, Viral; Prednisone; SARS-CoV-2; Severity of Illness Index; Tacrolimus | 2020 |
"Reversed halo sign" on 3D CT in COVID-19.
Topics: Adult; Antimalarials; Antiviral Agents; Betacoronavirus; Body Fluids; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Hydroxychloroquine; Imaging, Three-Dimensional; Male; Nasopharynx; Oseltamivir; Pandemics; Pneumonia; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Deprescriptions; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Humans; Hypertension; Immunoglobulins, Intravenous; Immunologic Factors; Iran; Lopinavir; Male; Mycophenolic Acid; Oseltamivir; Pandemics; Pemphigoid, Benign Mucous Membrane; Pneumonia, Viral; Prednisolone; Ritonavir; Rituximab; SARS-CoV-2; Tomography, Spiral Computed | 2020 |
Family cluster of three recovered cases of pneumonia due to severe acute respiratory syndrome coronavirus 2 infection.
Topics: Adult; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Family Health; Female; Genome, Viral; Humans; Male; Methylprednisolone; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Dynamic changes in routine blood parameters of a severe COVID-19 case.
Topics: Anti-Bacterial Agents; Betacoronavirus; Biomarkers; Blood Platelets; C-Reactive Protein; Cell Count; Convalescence; Coronavirus Infections; COVID-19; Erythrocytes; Female; Humans; Middle Aged; Monocytes; Neutrophils; Oseltamivir; Pandemics; Pneumonia, Viral; Prognosis; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index | 2020 |
Dozens of coronavirus drugs are in development - what happens next?
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Coronavirus Infections; COVID-19; Drug Development; Drug Industry; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral | 2020 |
Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.
Topics: Aged; Antineoplastic Agents, Immunological; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Lung Neoplasms; Melanoma; Multiple Chronic Conditions; Nivolumab; Oseltamivir; Pandemics; Pneumonia, Viral; Programmed Cell Death 1 Receptor; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Covid-19 and exacerbation of psoriasis.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral; Psoriasis; SARS-CoV-2 | 2020 |
SARS-CoV-2 persisted in lung tissue despite disappearance in other clinical samples.
Topics: Aged; Antiviral Agents; Betacoronavirus; Blood Loss, Surgical; Blood Volume; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Extracorporeal Membrane Oxygenation; Fatal Outcome; Humans; Hypertension; Lung; Lung Transplantation; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Respiration, Artificial; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed; Virus Shedding | 2020 |
COVID-19: Stay Cool toward Corticosteroids.
Topics: Adrenal Cortex Hormones; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Humans; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Modeling mitigation of influenza epidemics by baloxavir.
Topics: Antiviral Agents; Betacoronavirus; Cell Proliferation; Coronavirus Infections; COVID-19; Dibenzothiepins; Epidemics; Humans; Influenza, Human; Morpholines; Orthomyxoviridae; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Public Health; Pyridines; Pyridones; RNA, Messenger; SARS-CoV-2; Seasons; Thiepins; Triazines; Viral Load; Virus Replication | 2020 |
Characteristics of the initial patients hospitalized for COVID-19: a single-center report
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Antihypertensive Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; Female; Fever; Health Personnel; Humans; Hydroxychloroquine; Hypertension; Intensive Care Units; Lung; Male; Middle Aged; Myalgia; Oseltamivir; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Travel; Turkey; Young Adult | 2020 |
Have the symptoms of patients with COVID-19 changed over time during hospitalization?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coronavirus Infections; Cough; COVID-19; Diarrhea; Dyspnea; Female; Fever; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Symptom Assessment; Young Adult | 2020 |
Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy?
Topics: Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Humans; Indans; Influenza A Virus, H1N1 Subtype; Lysophospholipids; Mice; Orthomyxoviridae Infections; Oseltamivir; Oxadiazoles; Pandemics; Pneumonia, Viral; SARS-CoV-2; Sphingosine; Sphingosine-1-Phosphate Receptors | 2020 |
COVID-19 Pulmonary Infection with Pneumothorax in a Young Patient.
Topics: Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus; Coronavirus Infections; Cough; COVID-19; Enoxaparin; Female; Fever; Humans; Hydroxychloroquine; Lung; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Pneumothorax; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2020 |
Corticosteroid, oseltamivir and delayed admission are independent risk factors for prolonged viral shedding in patients with Coronavirus Disease 2019.
Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Female; Hospitalization; Humans; Immunoglobulins; Indoles; Interferons; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Retrospective Studies; Risk Factors; SARS-CoV-2; Time Factors; Virus Shedding | 2020 |
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
Topics: Animals; Antiviral Agents; Betacoronavirus; Binding Sites; Cell Line; Coronavirus Infections; COVID-19; Crotonates; Cytokine Release Syndrome; Dihydroorotate Dehydrogenase; Drug Evaluation, Preclinical; Gene Knockout Techniques; Humans; Hydroxybutyrates; Influenza A virus; Leflunomide; Mice; Mice, Inbred BALB C; Nitriles; Orthomyxoviridae Infections; Oseltamivir; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Pandemics; Pneumonia, Viral; Protein Binding; Pyrimidines; RNA Viruses; SARS-CoV-2; Structure-Activity Relationship; Thiazoles; Toluidines; Ubiquinone; Virus Replication | 2020 |
Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase.
Topics: Animals; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dihydroorotate Dehydrogenase; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Mice; Molecular Structure; Orthomyxoviridae Infections; Oseltamivir; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Pandemics; Pneumonia, Viral; Pyrimidines; SARS-CoV-2 | 2020 |
Protective potential of expectorants against COVID-19.
Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dioxolanes; Expectorants; Humans; Medicine, Chinese Traditional; Mucus; Oseltamivir; Pandemics; Pneumonia, Viral; Povidone; SARS-CoV-2 | 2020 |
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?
Topics: Adalimumab; Adult; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Azathioprine; Betacoronavirus; Biological Therapy; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Drug Combinations; Drug Therapy, Combination; Humans; Lopinavir; Male; Methotrexate; Oseltamivir; Pandemics; Pneumonia, Viral; Prednisolone; Ritonavir; SARS-CoV-2 | 2020 |
Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016.
Topics: Aged; Anti-Bacterial Agents; Antiviral Agents; Coronavirus Infections; Female; Hospitalization; Humans; Male; Middle Aged; Middle East Respiratory Syndrome Coronavirus; Oseltamivir; Oxygen Inhalation Therapy; Paris; Patient Isolation; Retrospective Studies; Saudi Arabia; Streptococcus pneumoniae; Travel; Treatment Outcome | 2018 |
Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014.
Topics: Antiviral Agents; Communicable Disease Control; Contact Tracing; Coronavirus; Coronavirus Infections; Disease Notification; Fatal Outcome; Humans; Malaysia; Middle Aged; Oseltamivir; Polymerase Chain Reaction; Population Surveillance; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Saudi Arabia; Syndrome; Travel | 2014 |
Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.
Topics: Amantadine; Antibody-Dependent Enhancement; Antiviral Agents; Coronavirus Infections; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza, Human; Neuraminidase; Orthomyxoviridae; Oseltamivir; Picornaviridae Infections; Respiratory Tract Infections; Rimantadine; Severe Acute Respiratory Syndrome; Texas; Virus Replication | 2016 |
Co-infections with influenza and other respiratory viruses.
Topics: Adult; Aged; Alphainfluenzavirus; Antiviral Agents; Child, Preschool; Coinfection; Coronavirus; Coronavirus Infections; Female; Humans; Immunocompromised Host; Influenza, Human; Male; Middle Aged; Oseltamivir; Parainfluenza Virus 3, Human; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections | 2013 |